Evidence map›Paper›PMID 42404584›Full record

ArticleInternational journal of microbiology2026

Uthaibhorn Singkham-In, Supadtra Pedcharat, Wilasinee Saisorn, Vorthon Sawaswong, Pornpimol Phuengmaung, Asada Leelahavanichkul

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Uthaibhorn Singkham-InDepartment of Clinical Microbiology, Faculty of Medical Technology, Rangsit University, Pathum Thani, Thailand, rsu.ac.th.ORCID https://orcid.org/0009-0002-2669-8868
Supadtra PedcharatCenter of Excellence in Translational Research in Inflammatory and Immunology (CETRII), Chulalongkorn University, Bangkok, Thailand, chula.ac.th.
Wilasinee SaisornCenter of Excellence in Translational Research in Inflammatory and Immunology (CETRII), Chulalongkorn University, Bangkok, Thailand, chula.ac.th.
Vorthon SawaswongDepartment of Biochemistry, Faculty of Science, Mahidol University, Bangkok, Thailand, mahidol.ac.th.
Pornpimol PhuengmaungCenter of Excellence in Translational Research in Inflammatory and Immunology (CETRII), Chulalongkorn University, Bangkok, Thailand, chula.ac.th.
Asada LeelahavanichkulCenter of Excellence in Translational Research in Inflammatory and Immunology (CETRII), Chulalongkorn University, Bangkok, Thailand, chula.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recently, bacteriophages have risen as a potent therapy for superbug infections. The mammal gut demonstrates an interesting source of virulence bacteriophages. The gut with inflammation is phage-rich; therefore, we primarily aimed to prove the concept that an inflammatory gut is a possible source of effective phages and to evaluate the efficacy of the candidate phage against Results: The gut microbiome of cecal ligation and puncture (CLP) sepsis mice, an animal model of inflammation, showed a dominant presence of Podoviruses. CLP bacteriophages (CLP Conclusions: The gut virome was a promising and interesting source of antimicrobial and immunomodulating bacteriophage.

Indexed as

bacteriophagebacteriophage therapycecal ligation and puncture (CLP) modelPseudomonas aeruginosaPseudomonas aeruginosa-infected wound modelwound infection

Identifiers

PMID42404584
PMCPMC13329690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.